This was the stock's third consecutive day of gains.

The licensing deal could set the US drugmaker to vie with Eli Lilly & Co. and Novo Nordisk A/S, the current leaders in a ...

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Over the past year, many AbbVie Inc. insiders sold a significant stake in the company which may have piqued investors' ...

AbbVie Inc. (NYSE:ABBV – Get Free Report) shares hit a new 52-week high on Friday . The company traded as high as $207.42 and ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

We recently published a list of 10 Best DRIP Stocks To Own Now. In this article, we are going to take a look at where AbbVie ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other S&P 500 dividend aristocrats sorted by hedge fund sentiment. Dividend Aristocrats are companies ...

Learn more about whether AbbVie Inc. or Regeneron Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Learn more about whether AbbVie Inc. or BeiGene, Ltd. is a better investment based on AAII's A+ Investor grades, which ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other psychedelic stocks. In contrast to drugs like cocaine or marijuana, psychedelics are strong ...